• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
Event Date 09/04/2020
Event Type  Injury  
Manufacturer Narrative
Journal article: clinical outcomes and angiographic results of bailout stenting for guide catheter-induced iatrogenic coronary artery dissection journal: circulation journal year: 2020 ref: doi: 10.1253/circj.Cj-20-0123.Death was reported as a clinical outcome of this study, however there is no information to suggest the device has caused or contributed to a death.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article titled - clinical outcomes and angiographic results of bailout stenting for guide catheter-induced iatrogenic coronary artery dissection, impact of stent type was submitted for review.This is a retrospective single-center study which aimed to describe the initial and long-term outcomes of bailout stenting for iatrogenic coronary artery dissection caused by non medtronic catheters and the differences between drug eluting stents (des) and bare-metal stents (bms).The study sample consisted of 93 patients undergoing bailout stenting, using either des (52) or bms (41).One resolute integrity drug eluting stent and two endeavor rx drug eluting stents were among the des used in this study, along with other non-medtronic des.Clinical outcomes included cardiac death, target lesion revascularization (tlr), spontaneous myocardial infarction (mi), definite or probable stent thrombosis (st) and major adverse cardiac events (mace).Mace consisted of cardiac death, nonfatal spontaneous mi, and tlr.Tlr was defined as a repeated coronary procedure for restenosis or thrombosis of the target lesion within the stent or within 5 mm proximal or distal to the stent on cag.Coronary artery dissection post bailout stenting only occurred in patients who had a non-medtronic des inserted.Three of the four reported cardiac deaths are confirmed to have occurred in patients with non-medtronic des.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RX
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11973224
MDR Text Key255343453
Report Number9612164-2021-02246
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P060033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 06/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/17/2021
Initial Date FDA Received06/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
-
-